Scott Henry
Stock Analyst at Alliance Global Partners
(1.24)
# 3,601
Out of 5,182 analysts
58
Total ratings
37.74%
Success rate
-6.11%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.80 | +275.94% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.01 | +271.29% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $1.01 | +494.06% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $2.30 | +334.78% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $18.14 | +127.40% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $5.19 | +63.78% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.01 | +298.01% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.32 | +546.55% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $240 | $0.91 | +26,233.11% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.08 | +23.46% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.88 | +19.49% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $35.53 | -32.45% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $231.78 | -61.17% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $26.07 | -40.54% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $115.00 | -49.57% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $92.93 | -61.26% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.05 | +947.62% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.06 | +47.78% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $0.72 | +795,087.39% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.31 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.90 | +678.12% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $14.34 | - | 5 | Apr 18, 2019 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.80
Upside: +275.94%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.01
Upside: +271.29%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $1.01
Upside: +494.06%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $2.30
Upside: +334.78%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $18.14
Upside: +127.40%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $5.19
Upside: +63.78%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.01
Upside: +298.01%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.32
Upside: +546.55%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $240
Current: $0.91
Upside: +26,233.11%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.08
Upside: +23.46%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $10.88
Upside: +19.49%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $35.53
Upside: -32.45%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $231.78
Upside: -61.17%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $26.07
Upside: -40.54%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $115.00
Upside: -49.57%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $92.93
Upside: -61.26%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.05
Upside: +947.62%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.06
Upside: +47.78%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $0.72
Upside: +795,087.39%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.31
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.90
Upside: +678.12%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $14.34
Upside: -